Newer Blood Thinners May Not Bring Higher Bleeding Risk
WEDNESDAY, Oct. 18, 2017 -- New anti-clotting drugs -- like Xarelto, Pradaxa and Eliquis -- aren ' t linked with a higher risk of bleeding than the older drug warfarin, a new study finds.
Many patients who suffer from blood clots in their legs --... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 18, 2017 Category: General Medicine Source Type: news
In VTE, Bleeding Risk No Higher with Direct Oral Anticoagulants Than Warfarin (FREE)
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Direct oral anticoagulants do not pose higher risk for major bleeding than warfarin in patients with venous thromboembolism (VTE), according … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 18, 2017 Category: Primary Care Source Type: news
Direct oral anticoagulants as safe as warfarin after VTE
Major bleeding or death no more likely with DOACs than with warfarin in first 90 days ’ treatment Related items fromOnMedica Antidotes for new oral anticoagulants – will they make a difference? Self-managing anticoagulants may cut risks after surgery Extending anticoagulation duration cuts risk of VTE recurrence NOACs instead of warfarin (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 18, 2017 Category: UK Health Source Type: news
CardioBrief: NOACs Not Linked To Excess Bleeding in Real World
(MedPage Today) -- Observational study compares new anticoagulants to warfarin in VTE (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - October 17, 2017 Category: Surgery Source Type: news
Outcomes May Be Better for Warfarin Users Who Stop Aspirin Use
Quality improvement effort tied to decrease in major bleeding without increase in thrombotic events (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 12, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Internal Medicine, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news
You won ’t believe what happened this morning
When I got to the office this morning, several of my employees were in a state of near-panic…
I couldn’t imagine what might have happened… and I was alarmed.
Turns out, the coffee maker was on the fritz.
Coffee is the “drug” of choice for many of the people on my staff. And they’re not alone…
An astounding 80% of Americans use the caffeine in coffee to boost their energy. The buzz helps them wake up every morning and gets their day going.
And older adults drink coffee more than anyone else. In fact, in a survey by the National Coffee Association, 20% of people over 64 said they would rather gi...
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news
Genetic testing improves blood thinner dosing
Researchers found that genetics-based dosing for the blood thinner warfarin reduces the risk of major side effects in older patients starting the medication. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - October 2, 2017 Category: Consumer Health News Source Type: news
Replacing Warfarin With a Novel Oral Anticoagulant Replacing Warfarin With a Novel Oral Anticoagulant
A good percentage of patients with atrial fibrillation may be ineligible for warfarin due to increased risk of major bleeding or recurrent systemic thromboembolism. Are DOACs a viable alternative?Journal of Cardiovascular Electrophysiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 2, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week ' s topics include aspirin discontinuation risks, HIV in those 50 and older, big data and chronic lung disease, and genetic testing and warfarin use (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 30, 2017 Category: Cardiology Source Type: news
Genetic testing may help determine appropriate dose of warfarin among patients undergoing hip or knee arthroplasty
Findings from a study published online in The Journal of the American Medical Association suggest that, compared to clinically guided dosing, genotype-guided warfarin dosing may reduce the risk of adverse events for joint arthroplasty patients. (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - September 30, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news
Drug safety update: Miconazole (Daktarin): over-the-counter oral gel contraindicated in patients taking warfarin
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update with advice that patients taking warfarin should not use over-the-counter miconazole oral gel (Daktarin). (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 29, 2017 Category: Drugs & Pharmacology Source Type: news
Genotype-Guided Warfarin Dosing Reduces Adverse Events After Hip, Knee Arthroplasty (FREE)
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Genotype-guided dosing of warfarin in older adults undergoing elective hip or knee arthroplasty helps prevent adverse events, according to a JAMA study.Roughly … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 27, 2017 Category: Primary Care Source Type: news
